Sulindac sulfide inhibits the proliferation of colon cancer cells: Diminished expression of the proliferation markers PCNA and Ki-67

被引:53
|
作者
Qiao, L
Shiff, SJ
Rigas, B
机构
[1] CORNELL UNIV,COLL MED,DEPT MED,NEW YORK,NY 10021
[2] ROCKEFELLER UNIV,NEW YORK,NY 10021
关键词
NSAIDs; colon cancer; sulindac; apoptosis; proliferation; cyclooxygenase;
D O I
10.1016/S0304-3835(97)04740-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We evaluated the effect of sulindac sulfide (SS), which reduces cell number and induces apoptosis in cultured colon cancer cells (CCCs), on expression of the proliferation markers PCNA and Ki-67 in HT-29 and HCT-15 CCCs; only the former express cyclooxygenases. DNA content and PCNA/Ki-67 expression were analyzed by bivariate flow cytometry. SS inhibited cell proliferation, determined by the reduced expression of PCNA and Ki-67, roughly by half at 72 h, and induced apoptosis (accounting for about two-thirds and one-third of the reduction in cell number, respectively). A similar effect of SS occurred in HT-29 and HCT-15 CCCs, and also in non-colonic cells, indicating that this rather general effect of SS on cultured cells is not dependent on inhibition of prostaglandin synthesis. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:229 / 234
页数:6
相关论文
共 50 条
  • [31] Apoptosis and cell proliferation in proliferative retinal disorders: PCNA, ki-67, caspase-3, and PARP expression
    Zhang, XY
    Barile, G
    Chang, S
    Hays, A
    Pachydaki, S
    Schiff, W
    Sparrow, J
    CURRENT EYE RESEARCH, 2005, 30 (05) : 395 - 403
  • [32] Physiological functions and roles in cancer of the proliferation marker Ki-67
    Andres-Sanchez, Nuria
    Fisher, Daniel
    Krasinska, Liliana
    JOURNAL OF CELL SCIENCE, 2022, 135 (11)
  • [33] Expression of the c-kit and ki-67 proliferation index in patients with lung cancer
    Basorgun, Cumhur Ibrahim
    Ozbilim, Gulay
    Ozbudak, Irern Hicran
    Sarper, Alpay
    Erdogan, Abdullah
    VIRCHOWS ARCHIV, 2007, 451 (02) : 427 - 427
  • [34] Immunohistochemical expression of Ki-67 as a marker of proliferation in gallbladder mucosa samples with or without cancer
    Roa E, Ivan
    Elorza D, Xabier
    Lantadilla H, Soledad
    Ibacache S, Gilda
    de Aretxabala U, Xabier
    REVISTA MEDICA DE CHILE, 2009, 137 (07) : 881 - 887
  • [35] Expression of PTEN and its correlation with proliferation marker Ki-67 in head and neck cancer
    Ahmed, Malik W.
    Kayani, Mahmood A.
    Shabbir, Ghulam
    Ali, Syed M.
    Shinwari, Wajih-ud-Din
    Mahjabeen, Ishrat
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2016, 31 (02): : E193 - E203
  • [36] Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia
    Zhong, Weide
    Peng, Jinyu
    He, HuiChan
    Wu, Dinglan
    Han, ZhaoDong
    Bi, XueCheng
    Dai, QiShan
    CLINICAL AND INVESTIGATIVE MEDICINE, 2008, 31 (01): : E8 - E15
  • [37] Expression of ki-67 as proliferation biomarker in imprint smears of endometrial carcinoma
    Konstantinos, Kosmas
    Marios, Stamoulas
    Anna, Marouga
    Nikolaos, Kavantzas
    Efstratios, Patsouris
    Paulina, Athanassiadou
    DIAGNOSTIC CYTOPATHOLOGY, 2013, 41 (03) : 212 - 217
  • [38] Expression of the proliferation marker Ki-67 during early mouse development
    Winking, H
    Gerdes, J
    Traut, W
    CYTOGENETIC AND GENOME RESEARCH, 2004, 105 (2-4) : 251 - 256
  • [39] PROLIFERATION ASSOCIATED PROTEIN EXPRESSION OF KI-67 AND REPP 86 IN COLORECTAL CANCER: HIGH KI-67 INDEX IS PROGNOSTIC FACTOR FOR CLINICAL OUTCOME
    Schrader, Carsten
    Gieseler, Frank
    Braesen, Jan H.
    Sipos, Bence
    Klapper, Wolfram
    Kalthoff, Holger
    von Schoenfels, Witigo
    Lucius, Ralph
    Nazzal, Saleh
    Hinz, Sebastian
    Pflueger, Christian
    Held, Harald
    Raff, Torsten
    Claasen, Jan
    Worth, Rona
    Kloeppel, Guenther
    Schafmayer, Clemens
    ANNALS OF ONCOLOGY, 2011, 22 : v115 - v116
  • [40] PROLIFERATION MARKERS IN GLIOMAS - A COMPARISON OF BUDR, KI-67, AND MIB-1
    DAVIS, RL
    ONDA, K
    SHUBUYA, M
    LAMBORN, K
    HOSHINO, T
    JOURNAL OF NEURO-ONCOLOGY, 1995, 24 (01) : 9 - 12